ArticleNanoscale2026
Film, function, flexibility: label-free nanobody sensors
Article in Nanoscale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rapid Electrochemical Impedance Detection of the MiACS omega · 2026Article
- Surface Functionalization Studies in the Development of Nanohole Plasmonic Sensors.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanobody-based biosensors promise exceptional molecular recognition and robustness, but their implementation has been limited by unstable and non-scalable surface chemistries. Here we introduce a materials platform that integrates stable electropolymerized tyramine nanofilms with label-free, non-faradaic electrochemical impedance spectroscopy for direct molecular detection. The electropolymerized nanofilms form amine-functionalized coatings that are electrically insulating yet chemically active, supporting site-specific covalent immobilization of nanobodies in controlled orientations. Target binding induces more than a 50% increase in the capacitance signal response, providing a distinct label-free signature of molecular recognition. The platform can be adapted to diverse bioreceptors and antifouling layers, offering a general route to chemically robust and scalable bioelectronic interfaces. By decoupling film conductivity from functional stability, this work establishes a new class of interfaces that bridge molecular design with label-free signal transduction for next-generation biosensing technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.